Merck's pause on an HIV program snowballs as a Gilead-partnered trial is shoved into limbo

Merck's announcement last week that an experimental HIV combo therapy resulted in a drop in immune cell counts, and its subsequent decision to ...


View article...


Top stories of the last 30 days